Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Study details and eligibility appear unchanged; formatting and layout updates are minor. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:27:04.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:32:37.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:21:49.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and 'Back to Top' removed. This is a straightforward version bump with a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:40:12.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-06T15:23:38.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and resources related to Acute Myeloid Leukemia, while some previous drug information and related resources have been removed.
    Difference
    8%
    Check dated 2025-08-30T11:59:17.000Z thumbnail image

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.